Good news: COVID-19 vaccine test is in the final stages!

The first vaccine tested for COVID-19 in the US increases the immunity of people according to the expectation of scientists. Scientists said this on Tuesday. The trial of this vaccine is now in the final stages. "Certainly this is good news," said Dr. Anthony Fauchi, the top expert on infectious diseases in the US government.

This vaccine has been developed by Fauchi's colleagues at the National Institutes of Health and Modern Inc. An important step towards the trial of this experimental vaccine will be taken around July 27, when research will be conducted on 30,000 people to find out how effective this vaccine is in protecting against corona virus.

However, on Tuesday, researchers revealed the findings of preliminary tests on 45 people, according to which the vaccine increases immunity.

Researchers were quoted in the New England Journal of Medicine as saying that the research found that these people had developed antibodies to eliminate the infection in their blood and that their levels were the same as the antibodies in people recovering from COVID-19.

Dr. Lisa Jackson of the Saffron Permanent Washigton Research Institute in Seattle, who led the research, says, "This is an important step that will determine whether the vaccine protects against infection." The

government hopes That its results will be revealed by the end of the year.

It is necessary to give two doses of this vaccine at a difference of one month. It has no serious side effects. Dr. William Schaffner, a vaccine specialist and associated with Vanderbilt University Medical Center, described the initial results as 'a good first step'. He hoped that the final test would be able to answer that it was indeed safe and effective. Around two dozen vaccines of Kovid-19 are being run in various stages across the world.